The FDA (the US drug regulator) looks set to ask companies for more proof before greenlighting any psychedelic as an official medicine in 2026. This means no psychedelic drug will become a standard, insurance-covered prescription treatment next year. People hoping for a legal medical option will need to wait longer.
No NDA action signals today; my duty is evidentiary rigor over hype. Phase 3 readouts alone rarely satisfy psychiatric durability concerns.